Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Kevin L. RakinIndependent Chairman & Lead Independent Director | -120,00k | 0,00 | Other Disposition | - | 398,54k | -23,14% |
| 2025-12-10 | Mr. Guido Julius NeelsIndependent Director | 6,25k | 0,00 | Derivative Exercise and Retained Stock | - | 125,00k | 5,26% |
| 2026-03-10 | Mr. Matthew B. FergusonCFO | -5,12k | 5,58k | Derivative Exercise and Sale | 1,09 | 472,07k | - |
| 2026-03-10 | Mr. Matthew B. FergusonCFO | 7,38k | 0,00 | Derivative Exercise and Retained Stock | - | 472,07k | 1,59% |
| 2026-03-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | -11,10k | 12,10k | Derivative Exercise and Sale | 1,09 | 409,41k | - |
| 2026-03-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 15,98k | 0,00 | Derivative Exercise and Retained Stock | - | 409,41k | 4,06% |
| 2026-03-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | 7,89k | 0,00 | Derivative Exercise and Retained Stock | - | 109,82k | 7,74% |
| 2026-03-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | -4,61k | 5,03k | Derivative Exercise and Sale | 1,09 | 109,82k | - |
| 2026-01-30 | Mr. Kevin L. RakinIndependent Chairman & Lead Independent Director | 70,00k | 74,20k | Kauf | 1,06 | 518,54k | 15,61% |
| 2026-01-30 | Mr. Guido Julius NeelsIndependent Director | 20,00k | 20,80k | Kauf | 1,04 | 118,75k | 20,25% |
| 2026-01-28 | Mr. Guido Julius NeelsIndependent Director | 30,00k | 31,80k | Kauf | 1,06 | 98,75k | 43,64% |
| 2025-12-17 | Mr. Kevin L. RakinIndependent Chairman & Lead Independent Director | 50,00k | 26,00k | Kauf | 0,52 | 448,54k | 12,55% |
| 2025-12-17 | Mr. Matthew B. FergusonCFO | 60,00k | 31,80k | Kauf | 0,53 | 447,11k | 15,50% |
| 2025-12-17 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 3,00k | 1,53k | Kauf | 0,51 | 379,20k | 0,80% |
| 2025-12-17 | Mr. David ColpmanIndependent Director | 12,50k | 6,38k | Kauf | 0,51 | 31,10k | 67,21% |
| 2025-12-17 | Ms. Brigid Ann MakesIndependent Director | 25,00k | 13,00k | Kauf | 0,52 | 27,00k | 1.250,00% |
| 2025-12-11 | HighCape Partners Management, L.P.Unternehmen | -4,51M | 0,00 | Other Disposition | - | 4,71M | -48,91% |
| 2025-12-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 17,42k | 0,00 | Derivative Exercise and Retained Stock | - | 376,20k | 4,85% |
| 2025-12-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | -9,66k | 6,76k | Derivative Exercise and Sale | 0,70 | 376,20k | - |
| 2025-12-10 | Mr. Matthew B. FergusonCFO | 8,04k | 0,00 | Derivative Exercise and Retained Stock | - | 387,11k | 2,12% |
| 2025-12-10 | Mr. Matthew B. FergusonCFO | -4,46k | 3,12k | Derivative Exercise and Sale | 0,70 | 387,11k | - |
| 2025-12-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | 8,55k | 0,00 | Derivative Exercise and Retained Stock | - | 101,93k | 9,15% |
| 2025-12-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | -3,95k | 2,77k | Derivative Exercise and Sale | 0,70 | 101,93k | - |
| 2025-12-01 | Mr. Matthew B. FergusonCFO | 10,00k | 6,61k | Kauf | 0,65 - 0,67 | 379,07k | 2,71% |
| 2025-12-01 | Mr. Guido Julius NeelsIndependent Director | 6,25k | 0,00 | Derivative Exercise and Retained Stock | - | 68,75k | 10,00% |
| 2025-11-24 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 5,00k | 3,00k | Kauf | 0,60 | 358,79k | 1,41% |
| 2025-11-17 | Mr. David ColpmanIndependent Director | 15,50k | 11,47k | Kauf | 0,74 | 18,60k | 500,32% |
| 2025-11-13 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 13,50k | 10,11k | Kauf | 0,74 - 0,76 | 353,79k | 3,97% |
| 2025-09-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | 8,55k | 0,00 | Derivative Exercise and Retained Stock | - | 93,39k | 10,08% |
| 2025-09-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | -3,95k | 5,37k | Derivative Exercise and Sale | 1,36 | 93,39k | - |
| 2025-09-10 | Mr. Matthew B. FergusonCFO | 18,65k | 0,00 | Derivative Exercise and Retained Stock | - | 369,07k | 5,32% |
| 2025-09-10 | Mr. Matthew B. FergusonCFO | -10,35k | 14,07k | Derivative Exercise and Sale | 1,36 | 369,07k | - |
| 2025-09-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 17,42k | 0,00 | Derivative Exercise and Retained Stock | - | 338,59k | 5,42% |
| 2025-09-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | -9,66k | 13,14k | Derivative Exercise and Sale | 1,36 | 338,59k | - |
| 2025-06-21 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 14,45k | 0,00 | Derivative Exercise and Retained Stock | - | 321,17k | 4,71% |
| 2025-06-21 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | -8,02k | 14,51k | Derivative Exercise and Sale | 1,81 | 321,17k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
